Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Wolfreys F"'
Autor:
Wolfreys, F
Though antibodies as therapeutics are limited to extracellular targets, their repertoire of molecular interactions has particular relevance to the many intracellular cellular proteins for which small molecule screening has reached impasse. For such p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::fad710eb501474a901d6475d9a9de5ce
https://ora.ox.ac.uk/objects/uuid:3dac2184-9532-49a4-aa7b-b06653d44a8c
https://ora.ox.ac.uk/objects/uuid:3dac2184-9532-49a4-aa7b-b06653d44a8c
Autor:
Lamy R; Department of Ophthalmology, University of California, San Francisco, CA 94158, USA., Wolf M; Department of Ophthalmology, University of California, San Francisco, CA 94158, USA., Bispo C; UCSF Parnassus Flow Cytometry Core Facility, University of California, San Francisco, CA 94143, USA., Clay SM; Department of Ophthalmology, University of California, San Francisco, CA 94158, USA., Zheng S; Department of Ophthalmology, University of California, San Francisco, CA 94158, USA., Wolfreys F; Department of Ophthalmology, University of California, San Francisco, CA 94158, USA., Pan P; Department of Ophthalmology, University of California, San Francisco, CA 94158, USA., Chan MF; Department of Ophthalmology, University of California, San Francisco, CA 94158, USA.; Francis I. Proctor Foundation, University of California, San Francisco, CA 94158, USA.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2022 Feb 25; Vol. 23 (5). Date of Electronic Publication: 2022 Feb 25.
Autor:
Kalinina, Elena1 (AUTHOR) kalinina-ev@rudn.ru
Publikováno v:
International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 15, p8423. 37p.
Autor:
Heroven C; Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Oxford, OX3 7DQ, UK., Georgi V; Bayer AG, Drug Discovery, Pharmaceuticals, Lead Discovery Berlin, 13353, Berlin, Germany., Ganotra GK; Molecular and Cellular Modeling Group, Heidelberg Institute for Theoretical Studies (HITS), 69118, Heidelberg, Germany.; Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences, Heidelberg University, 69120, Heidelberg, Germany., Brennan P; Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Oxford, OX3 7DQ, UK.; Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7FZ, UK., Wolfreys F; Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Oxford, OX3 7DQ, UK.; Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7FZ, UK., Wade RC; Molecular and Cellular Modeling Group, Heidelberg Institute for Theoretical Studies (HITS), 69118, Heidelberg, Germany.; Zentrum für Molekulare Biologie der Universität Heidelberg, DKFZ-ZMBH Alliance, Heidelberg University, 69120, Heidelberg, Germany.; Interdisciplinary Center for Scientific Computing, Heidelberg University, 69120, Heidelberg, Germany., Fernández-Montalván AE; Bayer AG, Drug Discovery, Pharmaceuticals, Lead Discovery Berlin, 13353, Berlin, Germany., Chaikuad A; Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Oxford, OX3 7DQ, UK.; Buchmann Institute for Molecular Life Sciences, Johann Wolfgang Goethe-University, 60438, Frankfurt am Main, Germany.; Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe-University, 60438, Frankfurt am Main, Germany., Knapp S; Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Oxford, OX3 7DQ, UK.; Buchmann Institute for Molecular Life Sciences, Johann Wolfgang Goethe-University, 60438, Frankfurt am Main, Germany.; Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe-University, 60438, Frankfurt am Main, Germany.; German Cancer Network (DKTK), Frankfurt/Mainz site, 60438, Frankfurt am Main, Germany.
Publikováno v:
Angewandte Chemie (International ed. in English) [Angew Chem Int Ed Engl] 2018 Jun 11; Vol. 57 (24), pp. 7220-7224. Date of Electronic Publication: 2018 May 09.
Autor:
Potapskyi, Eduard potapskiyed@gmail.com, Kustrzyńska, Karolina, Łażewski, Dawid, Skupin-Mrugalska, Paulina, Lesyk, Roman
Publikováno v:
Journal of Medical Science. 2024, Vol. 93 Issue 3, p227-248. 22p.
Autor:
Mathea S; Structural Genomics Consortium (SGC), Nuffield Department of Medicine, University of Oxford , Oxford, OX37DQ, United Kingdom.; Target Discovery Institute (TDI), Nuffield Department of Medicine, University of Oxford , Oxford, OX37FZ, United Kingdom., Abdul Azeez KR; Structural Genomics Consortium (SGC), Nuffield Department of Medicine, University of Oxford , Oxford, OX37DQ, United Kingdom., Salah E; Structural Genomics Consortium (SGC), Nuffield Department of Medicine, University of Oxford , Oxford, OX37DQ, United Kingdom.; Target Discovery Institute (TDI), Nuffield Department of Medicine, University of Oxford , Oxford, OX37FZ, United Kingdom., Tallant C; Structural Genomics Consortium (SGC), Nuffield Department of Medicine, University of Oxford , Oxford, OX37DQ, United Kingdom.; Target Discovery Institute (TDI), Nuffield Department of Medicine, University of Oxford , Oxford, OX37FZ, United Kingdom., Wolfreys F; Target Discovery Institute (TDI), Nuffield Department of Medicine, University of Oxford , Oxford, OX37FZ, United Kingdom., Konietzny R; Target Discovery Institute (TDI), Nuffield Department of Medicine, University of Oxford , Oxford, OX37FZ, United Kingdom., Fischer R; Target Discovery Institute (TDI), Nuffield Department of Medicine, University of Oxford , Oxford, OX37FZ, United Kingdom., Lou HJ; Department of Pharmacology, Yale University School of Medicine , New Haven, Connecticut 06520, United States., Brennan PE; Target Discovery Institute (TDI), Nuffield Department of Medicine, University of Oxford , Oxford, OX37FZ, United Kingdom., Schnapp G; Lead Discovery and Optimisation Support, Boehringer Ingelheim Pharma GmbH & Co KG , Biberach, 88400, Germany., Pautsch A; Lead Discovery and Optimisation Support, Boehringer Ingelheim Pharma GmbH & Co KG , Biberach, 88400, Germany., Kessler BM; Target Discovery Institute (TDI), Nuffield Department of Medicine, University of Oxford , Oxford, OX37FZ, United Kingdom., Turk BE; Department of Pharmacology, Yale University School of Medicine , New Haven, Connecticut 06520, United States., Knapp S; Target Discovery Institute (TDI), Nuffield Department of Medicine, University of Oxford , Oxford, OX37FZ, United Kingdom.; Institute for Pharmaceutical Chemistry and Buchmann Institute for Molecular Life Sciences (BMLS), Johann Wolfgang Goethe University , Frankfurt am Main, 60438, Germany.
Publikováno v:
ACS chemical biology [ACS Chem Biol] 2016 Jun 17; Vol. 11 (6), pp. 1595-602. Date of Electronic Publication: 2016 Mar 31.
Autor:
Rakhmatullin, Emil, Kadikov, Ilnur, Zaynullin, Lenar, Sagdeev, Danil, Kurshakova, Ekaterina, Mukhammadiev, Rinat, Mukhammadiev, Rishat, Galyautdinova, Gulnara, Vafin, Iskander
Publikováno v:
BIO Web of Conferences; 10/9/2024, Vol. 129, p1-6, 6p
Autor:
Johansen, Valdemar Brimnes Ingemann1 (AUTHOR), Snieckute, Goda1 (AUTHOR), Vind, Anna Constance1 (AUTHOR), Blasius, Melanie1 (AUTHOR), Bekker-Jensen, Simon1 (AUTHOR) sbj@sund.ku.dk
Publikováno v:
Cells (2073-4409). Mar2023, Vol. 12 Issue 6, p969. 15p.
Autor:
Nguyen HT; Lymphoid Malignancies Branch, Center for Cancer Research, NCI NIH, Bethesda, MD, USA., Li M; Lymphoid Malignancies Branch, Center for Cancer Research, NCI NIH, Bethesda, MD, USA., Vadakath R; Lymphoid Malignancies Branch, Center for Cancer Research, NCI NIH, Bethesda, MD, USA., Henke KA; Gnotobiotics Facility, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD, USA., Tran TC; Precision Health Informatics Section, NHGRI NIH, Bethesda, MD, USA., Li H; Lymphoid Malignancies Branch, Center for Cancer Research, NCI NIH, Bethesda, MD, USA., Yamadi M; Lymphoid Malignancies Branch, Center for Cancer Research, NCI NIH, Bethesda, MD, USA., Darbha S; Lymphoid Malignancies Branch, Center for Cancer Research, NCI NIH, Bethesda, MD, USA., Yang Y; Lymphoid Malignancies Branch, Center for Cancer Research, NCI NIH, Bethesda, MD, USA., Kabat J; Research Technologies Branch, NIAID NIH, Bethesda, MD, USA., Albright AR; Lymphoid Malignancies Branch, Center for Cancer Research, NCI NIH, Bethesda, MD, USA., Centeno EG; Lymphoid Malignancies Branch, Center for Cancer Research, NCI NIH, Bethesda, MD, USA., Phelan JD; Lymphoid Malignancies Branch, Center for Cancer Research, NCI NIH, Bethesda, MD, USA., Roulland S; Lymphoid Malignancies Branch, Center for Cancer Research, NCI NIH, Bethesda, MD, USA., Huang DW; Lymphoid Malignancies Branch, Center for Cancer Research, NCI NIH, Bethesda, MD, USA., Kelly MC; Single Cell Analysis Facility, Center for Cancer Research, NCI NIH, Bethesda, MD, USA., Young RM; Lymphoid Malignancies Branch, Center for Cancer Research, NCI NIH, Bethesda, MD, USA., Pittaluga S; Laboratory of Pathology, Center for Cancer Research, NCI NIH, Bethesda, MD, USA., Difilippantonio S; Gnotobiotics Facility, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD, USA., Muppidi JR; Lymphoid Malignancies Branch, Center for Cancer Research, NCI NIH, Bethesda, MD, USA. jagan.muppidi@nih.gov.
Publikováno v:
Nature immunology [Nat Immunol] 2024 Sep; Vol. 25 (9), pp. 1718-1730. Date of Electronic Publication: 2024 Jul 18.
Autor:
Hauser, Alexander S.1 (AUTHOR) alexander.hauser@sund.ku.dk, Gloriam, David E.1 (AUTHOR), Bräuner‐Osborne, Hans1 (AUTHOR), Foster, Simon R.1,2 (AUTHOR) simon.foster@monash.edu, Bräuner-Osborne, Hans1 (AUTHOR)
Publikováno v:
British Journal of Pharmacology. Mar2020, Vol. 177 Issue 5, p961-968. 8p. 1 Diagram, 1 Chart, 1 Graph.